Francais
info@saveyourskin.ca

Melanoma in Canada: A Short Review of the Past Ten Years

In the decade since the Save Your Skin Foundation began, the Canadian melanoma landscape has seen both positive and negative changes. Advances in treatment methods and greater availability of trial drugs has increased survivorship rates, yet melanoma remains one of the only preventable cancers that has not seen a decline in diagnosis’. Review of the data found in the Canadian Cancer Society’s Canadian Cancer Statistics 2014, Special Topic: Skin Cancers and 2015, Special Topic: Predictions of the Future Burden of Cancer in Canada reveals that more Canadians are being diagnosed with melanoma than ever before.
Melanoma diagnosis rates have risen considerably in the past decade; in 2006, it was estimated that melanoma accounted for 13.6 of every 100,000 male cancer diagnosis’, and 11 of every 100,000 female cancer diagnosis’. This number has climbed to 16.1/100,000 cases for males and 13.2/100,000 for females in 2015 (2015 26-27). Given that the largest risk factor for melanoma is UV exposure, it is possible that this rise is due to the increasing popularity of tanning beds; this suggestion is supported by the yearly increase of 2.9% of melanoma cases among women between 2001-2010, versus 2.3% per year for men between in the same time period (21). However, melanoma is still more prevalent in males than in females; the Canadian Cancer Society estimated that in 2014, 1 in 59 Canadian men would develop melanoma with a 1 in 290 mortality rate, while 1 in 73 Canadian women would develop melanoma with a 1 in 395 mortality rate (2014 78).
While these numbers are growing, so are the survival rates of melanoma in Canada. Based on their follow-up data from between 2004 and 2008, the Canadian Cancer Society found “the one-, five-, and [ten]-year predicted relative survival ratios (RSRs) [to be] 97%, 89% and 86% respectively” (83). The CCS also found that the five-year predicted relative survival ratio has risen “from 85% in 1992-1996 to 89% in 2004-2008” (83), likely due to the rise of new treatment opportunities for melanoma patients.
While the incidence and mortality rates are higher in adult than adolescent Canadians (2014 77), statistics demonstrate that childhood sun safety is critical. Skin cancer is the second most diagnosed among Canadian youth 15-35 years old (Canadian Skin Cancer Foundation, “About Skin Cancer”), and the Canadian Cancer Society has found links between intermittent and intense sun exposure (resulting in burns) in adolescence and the development of skin cancers later in life (2014 87). It is imperative that parents ensure their children are protected during their outdoor activities, not only during their summer activities but also while partaking in winter sports, as snow can reflect UV rays. Preventing sunburns in adolescence, and teaching children about sun safety, can reduce their chances of developing melanoma as an adult.
Maintaining a sun safe attitude is not just important as an adolescent; no tan is a safe tan, and exposure to UV rays at any stage in life can contribute to the development of melanoma! If you are interested in reading more about sun safety, Save Your Skin’s recent blog post on the topic can be found here. For more information about cancers in Canada, we recommend a read of the Canadian Cancer Society’s Canadian Cancer Statistics 2014, Special Topic: Skin Cancers and 2015, Special Topic: Predictions of the Future Burden of Cancer in Canada. Thank you for reading, and remember sun safety during your outdoor activities!

 

Works Cited:

Canadian Cancer Society’s Advisory Committee on Cancer Statistics (2014). Canadian Cancer Statistics 2014. Web.

Canadian Cancer Society’s Advisory Committee on Cancer Statistics (2015). Canadian Cancer Statistics 2015. Web.

Canadian Skin Cancer Foundation. “About Skin Cancer”. Web.

Read more

Understanding the pan-Canadian Pharmaceutical Alliance (pCPA) and how it affects those fighting skin cancer

Guest blog post by Elizabeth Eakin

Within Canada, many patients are forced to move outside of their homes to receive the treatment they need. As skin cancer is affecting more and more Canadians each year, a high volume of patients all over Canada are forced to travel in order to receive their suited treatment. Currently, Melanoma is the fasting growing cancer in Canada, with an estimated 6,800 diagnosed in 2015. As the incidence continues to increase, greater access and availability to treatment are needed. One of Save Your Skin foundations immediate goals is to provide melanoma patients with access to information about trial drugs as well as provide financial support to allow patients access to their suited treatment. This is an intricate and expensive task that takes knowledge of the drug process within Canada to fully understand.

Within Canada, drug authorization of sales is an extremely long process. It can take up to two years before the drug is approved for review. During these transparent years, the trial drug undergoes scientific testing’s regarding safety, effectiveness and quality of manufacturing. From there, the pan-Canadian Oncology Drug review products, Common Drug Review (CDR) and the non-oncology drugs review (pCODR) overlook the drug. The review time includes comparisons to existing drugs on the market as well as cost-effective evaluations. Once assessed, the review is sent out to all participating federal, provincial and territorial drug benefit plans in Canada, which make the pan-Canadian Pharmaceutical Alliance (pCPA). They decide whether joint pan-Canadian negotiations will occur for the drug product. If they decide to move forward, one jurisdiction will lead with the manufacturer, while an agreement between all other participating jurisdictions will be signed. If an agreement can be reached between participating jurisdictions and the manufacturer, a letter of intent will be signed and shared with all participating jurisdictions. After the pCPA process, each jurisdiction is then responsible for individually making a decision on funding through their public drug plan. These plans are then entered into a jurisdiction specific product listing agreement with the manufacturer.

After this long process individuals can gain access to the pharmaceutical drug depending if the province supports and funds it. The specificity of which provinces/territories provide access and funding makes the process long and tumultuous. In order for each patient to get the treatment they need, many need to travel, adding further expenses and stress. For those struggling with skin cancer, the Save Your Skin foundation does all it can to provide patients with access to trial treatments as well as financial and emotional support. As a foundation, we want to help each patient receive the best individual care possible, so they can fight their hardest against this disease.

Figure 1: pan- Canadian Pharmaceutical Alliance

Chart

Read more

Save Your Skin Weekly Flashback [June 25th-July 1st, 2016]

Welcome to the Save Your Skin Foundation media flashback- your weekly guide to the melanoma landscape, and the activities of the Save Your Skin Foundation! It’s an exciting week for the skin cancer community, with the Post-ASCO 2016 Conference in Munich, Germany and the Summit for Cancer Immunotherapy (Canadian Cancer Immunotherapy Consortium and BioCanRx) in Halifax, Nova Scotia, which Save Your Skin Founder Kathy Barnard opened with a discussion of life “beyond the curve” of melanoma. Keep an eye on our facebook page and twitter for updates on both conferences!

We are also excited to announce that we have been featured in the Summer 2016 issue of Canadian Skin, which includes a profile on the Save Your Skin Foundation and a testimonial from one of our board members, Christian Mosley!

Finally, we are still running our survey on sun safety behaviour, which you can fill out here. We appreciate it!

immunotherapysummit

 

Here are some links and images we shared with you this week:

 

– This image from Post-ASCO in Munich, which suggests an alteration to the ABCDE (now the ABCD!) rules of clinical mole recognition:

newabcd

This article from Modern Medicine Network outlining the S3 international guidelines for actinic keratosis

This article from Dermatology News reporting the findings of a study done by the US National Cancer Institute’s Surveillance, Epidemiology, and End Results program (SEER), which “highlight[s] the heavy death toll of thin melanomas”

This article from Ecancernews reporting the suggested links between immunotherapy drugs, such as ipilimumab and nivolumab, and arthritis

This News Wire article announcing that Merck has approved Keytruda for the treatment of patients with unresectable or metastatic melanoma that have not been treated with ipilimumab

This article in Bel Marra Health suggesting that the development of vitiligo may be indicative of immunotherapy response

This article in Trib Live about awesome Mohs histologist Danielle Deroy Pirain, who had a sunscreen dispenser installed in Mt Lebanon Park, Pennsylvania!

This link to the Aim at Melanoma Foundation’s Memorial Wall. If you would like to include a loved one’s name on the Memorial Wall, you can do so here.

-And this Fierce Medical Devices article about the partnership between Australia’s IBM Research and Melanoma Institute Australia to build on IBM’s MoleMap, which seeks to identify patterns in early stage melanoma

 

 

Thank you for reading, be sun safe out there!

 

sunsafety

Read more

Danika’s Story

Montréal, QC

I was 19 years old when I had my first contact with melanoma. I had a beauty mark on my back and it began to grow bigger and had a reddish hue.

A dermatologist did a biopsy and I had the diagnosis on December 28 2011; I was 19 and I had a malignant melanoma, the most serious form of skin cancer. I had a PET scan and a lymphoscintigraphy. Fortunately, at that time, I had no metastases. I had an operation to remove the beauty mark and the skin below and I was told that everything was fine. I only kept a scar shaped like a bird as a souvenir.

However, two years later, I was stage four melanoma.
The previous weeks, some lumps grew on my abdomen, my chest, and even my face. So we did biopsies and it was subcutaneous metastases. A PET scan later, I learned that I also had metastases to the liver, lungs and bones. At that time, I knew it was serious, but I had no idea how my life was about to change.

I was quickly supported by my hospital, the CHUM Notre-Dame, who proposed me to be part of a research protocol. I started taking tablets of « LGX818 », it was so new that they did not even have an official name yet. They were anti-BRAF drugs, since I had the BRAF mutation. One of the worst side effects that I had was peripheral neuropathy. It felt like having electrical shocks in my body. Then came the first scans results ; the treatment was working since some metastases decreased volume and no new one had appeared. Muscle pain, nerve, joint, skin problems, all of it was now worth it.

However, a few weeks after starting treatment, a new side effect appeared. In medical parlance, it is called “alopecia”. More simply, it means hair loss. Of course when you think chemotherapy you think hair loss, but my treatment was not supposed to do that, so I wasn’t prepared. In a few weeks I had to witness the loss of at least 50% of my hair, and believe me, I had a lot of hair! I found some in my bed, in the shower, on the couch, carpet, everywhere … I couldn’t take it anymore so I asked my mother to shave all of it. I anticipated this moment and yet none of us has shed tears. To my surprise, I was not so bad without hair. I still decided to wear a wig to school, to avoid passing from one extreme to the other and catch the eye of everyone.

After nearly 8 months of treatments, I had an appointment with my oncologist and I felt that something was wrong. Indeed, the latest scan results showed new lesions. My body got used to the medication and became resistant to it. We had to change treatment. New drugs were just emerging in Canada and were offering promising results. However, we must pass through a conventional chemotherapy before gaining access to the other treatments. These new treatments cost a lot of money so you have to « try everything » before.

A week later, it was time for that chemotherapy called Dacarbazine. It was the first time I found myself in these kinds of rooms, you know the rooms where there are several chairs next to each other, and on which are literally plugged patients. And of course, most patients are older and the majority have no hair. The image gives a shock. However, once installed in my chair, I noticed that the atmosphere was not so bad.

The next days were very difficult. I had nausea, fatigue and flu-like symptoms. I was going to school when my condition would let me. My next dose was scheduled three weeks later but it never took place. Bumps had appeared on my body; Dacarbazine wasn’t working on me at all. At least, now I had access to the new treatment. Again, I had to change course.

The new treatment, Yervoy, was actually immunotherapy, which rely on our natural immune system to destroy cancer cells, that’s the essence of immunotherapy. A few days later, on May 14, the day before my birthday, I found myself once again in the treatment room, but this time with another liquid pouring into my veins.

The first shot was held pretty well and I could finish my session. In addition, hair began to appear on my skull. However, bad news came back; I started to feel horrible abdominal pain. I even felt my tumors growing back. On the abdomen, I had a big lump like a cherry, right under my skin. So I felt it constantly.

I went to the hospital and the on-call oncologist decided to do the scans and all the tests right then. She came back several hours later with the results … Just by the look on his face, his way of coming to me, I felt it was bad. He sat on my bed, took my hand and said: “The news are not good, tumors got bigger, especially the one on the liver and it’s probably what’s causing your pain. ”

So … we turned to a fourth type of treatment in one year. I was exhausted. This was the latest treatment available in Canada for melanoma. It was still immunotherapy, but called Pembrolizumab (Keytruda).

The first Keytruda treatment went well. A few days later, the pain seemed to lessen a bit. I got to do some activities, saw some friends, etc. A few weeks later, the scan results finally brought some good news; after only 3 shots, metastases were reduced by approximately 50%! And I had almost no side effects; only fatigue the days following treatment, as well as vitiligo that appeared on my body.

So here I am, May 2016, I just turned 24 years two days ago, and my current treatment, pembrolizumab, is finally working. I had 13 shots so far and I will continue for at least another year. I hope that future scans will be even better than the last ones. I got back to school, my hair grew back and I can finally start to enjoy life again!

Those last two years were a roller coaster of emotions. We all have the right, at times, to be afraid and desperate. The important thing is to get up and always keep in the back of our mind the hope to believe that everything will be fine.

 

Request to Connect

Read more

Save Your Skin Weekly Flashback [June 18-24, 2016]

Welcome to the Save Your Skin Foundation media flashback- your weekly guide to the melanoma landscape, and the activities of the Save Your Skin Foundation! It’s the first week of summer in the Western world, which means it’s definitely time to start thinking about sun safety! Check out our recent blog about sun safety here. We’re also running a summer sun safety behaviour survey, which we would love for you to fill out! You can find it here.

 

If you missed the flashback last week, it is our pleasure to inform you that Save Your Skin Founder Kathy Barnard was awarded a BC Community Achievement Award in May! Shaw TV will be airing the event for the rest of June and into July; a broadcasting schedule can be found here.
Here are some images and links we shared with you this week:
melanomaecard

  • This cute video from Leo Pharmaceuticals about sun safety
  • This article from Sundicators about protecting your skin from the sun 
  • The American Academy of Dermatology’s new Melanoma PSA, “‘Arms’” 
  • This link to the draft of the Government of Canada’s Guidelines for Tanning Equipment Owners, Operators, and Users, with a feedback opportunity 
  • This article in Targeted Oncology announcing that the Melanoma Institute Australia and the University of Sydney have deemed the combination of pembrolizumab and ipilimumab as a safe treatment for advanced melanoma 
  • This article in Fierce Pharma that the National Institute for Health and Care Excellence has approved Bristol-Meyer’s combination of Opdivo and Yervoy for advanced melanoma patients
  • This Today piece about the “Mr. Sun” campaign, which aims to warn families about the possibly severe consequences of childhood burns 
  • This HelloGiggles article debunking 13 myths about sunscreen and skin cancer 
  • This piece from Cure Today  about the 2014 Cancer Experience Registry Report, “Elevating the Patient Voice”

molediagram

Read more

Danika’s Story: I was 19 years old when I had my first contact with melanoma

 – Guest Blog Post by Danika 
IMG_3071

I was 19 years old when I had my first contact with melanoma. I had a beauty mark on my back and it began to grow bigger and had a reddish hue.

A dermatologist did a biopsy and I had the diagnosis on December 28 2011; I was 19 and I had a malignant melanoma, the most serious form of skin cancer. I had a PET scan and a lymphoscintigraphy. Fortunately, at that time, I had no metastases. I had an operation to remove the beauty mark and the skin below and I was told that everything was fine. I only kept a scar shaped like a bird as a souvenir.

However, two years later, I was stage four melanoma.
The previous weeks, some lumps grew on my abdomen, my chest, and even my face. So we did biopsies and it was subcutaneous metastases. A PET scan later, I learned that I also had metastases to the liver, lungs and bones. At that time, I knew it was serious, but I had no idea how my life was about to change.

I was quickly supported by my hospital, the CHUM Notre-Dame, who proposed me to be part of a research protocol. I started taking tablets of « LGX818 », it was so new that they did not even have an official name yet. They were anti-BRAF drugs, since I had the BRAF mutation. One of the worst side effects that I had was peripheral neuropathy. It felt like having electrical shocks in my body. Then came the first scans results ; the treatment was working since some metastases decreased volume and no new one had appeared. Muscle pain, nerve, joint, skin problems, all of it was now worth it.

However, a few weeks after starting treatment, a new side effect appeared. In medical parlance, it is called “alopecia”. More simply, it means hair loss. Of course when you think chemotherapy you think hair loss, but my treatment was not supposed to do that, so I wasn’t prepared. In a few weeks I had to witness the loss of at least 50% of my hair, and believe me, I had a lot of hair! I found some in my bed, in the shower, on the couch, carpet, everywhere … I couldn’t take it anymore so I asked my mother to shave all of it. I anticipated this moment and yet none of us has shed tears. To my surprise, I was not so bad without hair. I still decided to wear a wig to school, to avoid passing from one extreme to the other and catch the eye of everyone.

After nearly 8 months of treatments, I had an appointment with my oncologist and I felt that something was wrong. Indeed, the latest scan results showed new lesions. My body got used to the medication and became resistant to it. We had to change treatment. New drugs were just emerging in Canada and were offering promising results. However, we must pass through a conventional chemotherapy before gaining access to the other treatments. These new treatments cost a lot of money so you have to « try everything » before.

A week later, it was time for that chemotherapy called Dacarbazine. It was the first time I found myself in these kinds of rooms, you know the rooms where there are several chairs next to each other, and on which are literally plugged patients. And of course, most patients are older and the majority have no hair. The image gives a shock. However, once installed in my chair, I noticed that the atmosphere was not so bad.

The next days were very difficult. I had nausea, fatigue and flu-like symptoms. I was going to school when my condition would let me. My next dose was scheduled three weeks later but it never took place. Bumps had appeared on my body; Dacarbazine wasn’t working on me at all. At least, now I had access to the new treatment. Again, I had to change course.

The new treatment, Yervoy, was actually immunotherapy, which rely on our natural immune system to destroy cancer cells, that’s the essence of immunotherapy. A few days later, on May 14, the day before my birthday, I found myself once again in the treatment room, but this time with another liquid pouring into my veins.

The first shot was held pretty well and I could finish my session. In addition, hair began to appear on my skull. However, bad news came back; I started to feel horrible abdominal pain. I even felt my tumors growing back. On the abdomen, I had a big lump like a cherry, right under my skin. So I felt it constantly.

I went to the hospital and the on-call oncologist decided to do the scans and all the tests right then. She came back several hours later with the results … Just by the look on his face, his way of coming to me, I felt it was bad. He sat on my bed, took my hand and said: “The news are not good, tumors got bigger, especially the one on the liver and it’s probably what’s causing your pain. ”

So … we turned to a fourth type of treatment in one year. I was exhausted. This was the latest treatment available in Canada for melanoma. It was still immunotherapy, but called Pembrolizumab (Keytruda).

The first Keytruda treatment went well. A few days later, the pain seemed to lessen a bit. I got to do some activities, saw some friends, etc. A few weeks later, the scan results finally brought some good news; after only 3 shots, metastases were reduced by approximately 50%! And I had almost no side effects; only fatigue the days following treatment, as well as vitiligo that appeared on my body.

So here I am, May 2016, I just turned 24 years two days ago, and my current treatment, pembrolizumab, is finally working. I had 13 shots so far and I will continue for at least another year. I hope that future scans will be even better than the last ones. I got back to school, my hair grew back and I can finally start to enjoy life again!

Those last two years were a rollercoaster of emotions. We all have the right, at times, to be afraid and desperate. The important thing is to get up and always keep in the back of our mind the hope to believe that everything will be fine.

Read more

A Sun Safety Reminder from The Save Your Skin Foundation!

Summer has officially begun, and while it’s off to a cloudy start here at Save Your Skin in Vancouver, it’s important to remember sun safety during your outdoor activities! Though it is tempting to get a tan during the summer, keep in mind that the Canadian Cancer Society cites exposure to ultraviolet radiation as the greatest risk factor for the development of skin cancer. Melanoma is often a preventable disease, yet it is estimated that in 2017, 7, 200 Canadians were diagnosed with melanoma skin cancer and 74, 000 with non-melanoma skin cancer. That is why it’s essential to keep sun safety in mind if you’re working or playing outside this summer!

If you choose to wear sunscreen, it should have at least SPF 30, with UVA and UVB protection. The high SPF ensures that you will be well protected if you apply every two hours, while UVA and UVB protection shields you from both longer and shorter UV rays, respectively. It is a good idea to reapply more frequently if you are sweating or swimming, as moisture can rinse away sunscreen, and if you are at the beach, as sand can reflect ultraviolet rays. Remember to apply sunscreen to areas which are often forgotten, such as the back of your neck, your ears, the backs of your hands and the tops of your feet. If you are concerned about the chemical compositions of sunscreen, you can stay sun safe with organic sunscreens, which contain zinc oxide as their only active ingredient. They are available at most drug stores. Whatever sunscreen you use, remember to apply it fifteen minutes before leaving the house, so the ingredients have time to be absorbed into your skin!

There are ways to protect yourself from UV rays as an alternative, or in addition, to wearing sunscreen. These include wearing sunglasses to protect your eyes and prevent ocular melanoma, and a hat to shield the top of your head and neck and long sleeved shirts and pants. It is wise to seek shade whenever possible, especially when you don’t have the protection of sunscreen or clothing.

Sun safety is especially important for children. There are links between intermittent and intense sun exposure (resulting in burns) in adolescence and the development of skin cancers later in life, and skin cancer is the second most commonly diagnosed cancer in Canadian youth from 15-35 years old. While it is a good idea to introduce your children to sun safety early, keep in mind that the developing skin of babies is sensitive to both UV damage and the chemicals found in sunscreen. It is therefore best practice to keep babies out of the sun as much as possible.

If you live in a city with inconsistent weather, it is important to be protected even when the sun isn’t shining. The Skin Cancer Foundation estimates that up to 40% of the sun’s ultraviolet radiation can still reach the earth through clouds, so it is important to consider sun safety even when the sky is grey. While we recommend wearing sunscreen every day, check a UV index app if you need convincing; if the UV index is higher than 3, the US Environmental Protection Agency recommends taking full sun safety measures. While we may take it for granted, the skin is our largest organ, and it deserves to be taken care of!

Thanks for reading! On behalf of the The Save Your Skin Foundation, have a great and sun safe summer!

 

 

Read more

Save Your Skin Weekly Flashback [June 10-17, 2016]

 

Welcome to the first Save Your Skin Foundation media flashback- your weekly guide to the melanoma landscape, and the activities of the Save Your Skin Foundation! The Save Your Skin Foundation is riding high on recent successes this week; in May, Save Your Skin Founder Kathy Barnard was awarded a BC Community Achievement Award, and the event is being re-broadcast by Shaw TV! The airing schedule can be found here. In addition, the donations have been counted and our recent #unbeach fundraiser raised $15, 000, which is enough to help fifteen patients with their treatment, transportation, and meal costs! These events, running alongside National Sun Awareness Week (June 2-12), have granted Save Your Skin a great start to the summer!

nationalsunawarenessweek

 

Here are some articles we shared with you this week:

  • This announcement by CNW that Canada’s Health Technology Assessment Agency has approved OPDIVO™ to treat non- small cell lung cancers
  • This PharmaTimes announcement that unfortunately, The National Institute for Health and Care Excellence has rejected use of Roche’s Cotellic/Zelboraf as a treatment for melanoma
  • This piece from the New England Journal of Medicine comparing the use of Pembrolizumab versus Ipilimumab in Advanced Melanoma
  • This article by the Indianapolis Star, which discusses the positive changes in the melanoma landscape thanks to new treatments
  • This article by Medscape about the dawn of ‘precision prevention’ of melanoma
  • This coverage by KCCI News down in Des Moines on the rising rates of melanoma in children and teenagers
  • This rundown by the Aim at Melanoma Foundation about genetic risk factors for melanoma
  • And this Bayshore Broadcasting coverage of the Canadian Cancer Society’s awesome Mudmoiselle fundraiser! If you’re in the Beaver Valley area, there is still time to register!

Thank you for supporting the Save Your Skin Foundation! Don’t forget sun safety while you’re outdoors this week, and we’ll see you on the next media flashback!


moreeducationplz

Read more

See SYS Founder Kathy Barnard Receive Award on Shaw TV!

Starting today, Shaw TV will be airing the BC Community Achievement Awards, one of the recipients being Save Your Skin Founder Kathy Barnard! See below for air times in your area!

Her Honour Lt. Gov. Judith Guichon presents awards to 32 BC recipients, for their outstanding contributions to their communities.
Length: 90 minutes
A shorter version is also available on the Foundation’s website: http://www.bcachievement.com/community/video.php?id=10
Air Times:
BC Interior
(starting June 15 and running to June 26)

Kelowna, Vernon-Salmon Arm, Penticton, Merritt, Williams Lake, Quesnel, Prince George – Wed, Fri, Sun @ 7pm
Kamloops – Wed @ 7pm, Fri @ 7 pm, Sun @ 5:30pm
Dawson Creek, Fort St. John – Wed @ 7pm, Fri @ 8pm, Sun @ 7pm

Shaw Metro Vancouver
As far east as Abbotsford and as far west as West Vancouver. All cities/communities in between: North & West Vancouver, Vancouver, Burnaby, Richmond, Surrey, Port Moody,
Port Coquitlam, Pitt Meadows, Maple Ridge, Abbotsford, Langley, New Westminster, White Rock.

Sun June 19 @9:30am
Tue June 21 @9:30pm
Fri June 24 @5:30pm
Sat June 25 @10:30am
Sun June 26 @11:30am
Sun July 3 @11pm
Wed June 29 @4:30pm

Shaw TV South Vancouver Island

Tue June 21st @ 1pm
Wed June 22nd @ 10pm
Thu June 23rd @ 6am
Sat June 25th @ 3pm
Sun June 26th @ 7pm

Read more

Announcing a new treatment for melanoma, along with two infographics (on Immuno-oncology and Melanoma), and new animated videos on cancer and immuno-oncology!

Announcing a new treatment for melanoma, along with two infographics (on Immuno-oncologY and Melanoma), and new animated videos on cancer and immuno-oncology!

Today, it was announced that KEYTRUDA® (pembrolizumab) received approval for the treatment of patients with unresectable or metastatic melanoma who have not received prior treatment with ipilimumab. KEYTRUDA is now the first and only anti-PD1 agent approved for first-line treatment regardless of BRAF mutation status.

A press release announcing this news was released earlier today and can be read here. The multi-media press release was issued with two infographics (on Immuno-oncology and Melanoma), and new animated videos on cancer and immuno-oncology.

We are also pleased to share to new amazing Patient Voice videos. We are continuously inspired by Save Your Skin Foundation patients, Mike and Pierre, who generously shared their stories for these videos.

Meet Mike: https://www.youtube.com/watch?v=rzCpNI7Huc8

Meet Pierre: https://www.youtube.com/watch?v=CiRdRboekYg

You can also see previous videos with Mike and Pierre on our I’m Living Proof website.

We are sharing all of this with you during an important time of year for skin cancer. Today marks the last day of Melanoma Awareness Month and it is the eve of International Cancer Immunotherapy Month (June). Save Your Skin Foundation will also be working to create further awareness of Sun Awareness Week (June 6-12) and National Cancer Survivor Day, which takes place on Sunday, June 5th.

Read more